View Older Stories View More Recent Stories

Apr 24, 2023 05:31PM Form SC 13D/A MDU RESOURCES GROUP INC Filed by: Corvex Management LP
Feb 14, 2023 03:56PM Form 13F-HR Corvex Management LP For: Dec 31
Feb 9, 2023 04:06PM Form 3 GeneDx Holdings Corp. For: Jan 31 Filed by: Corvex Management LP
Jan 24, 2023 05:21PM Form SC 13D/A MDU RESOURCES GROUP INC Filed by: Corvex Management LP
Jan 24, 2023 05:12PM MDU Resources Group (MDU) Enters Cooperation Agreement With Corvex Management
Jan 24, 2023 05:10PM MDU Resources Enters Into Cooperation Agreement With Corvex Management
Dec 22, 2022 09:54PM Kindred's Nomination Committee proposes five new members to the Board of Directors
Nov 14, 2022 04:03PM Form 13F-HR Corvex Management LP For: Sep 30
Nov 3, 2022 04:05PM Form SC 13D/A MDU RESOURCES GROUP INC Filed by: Corvex Management LP
Oct 20, 2022 05:25AM Notice to Extraordinary General Meeting of Kindred Group plc
Sep 27, 2022 04:07AM Nomination Committee ahead of Kindred's 2023 Annual General Meeting
Aug 15, 2022 04:01PM Form 13F-HR Corvex Management LP For: Jun 30
Aug 11, 2022 06:28AM Notification of major holdings in Kindred Group plc
Aug 10, 2022 02:50AM Corvex Management Advises Kindred Group PLC of 15% Ownership and Plan to Participate on Nomination Committee
Aug 9, 2022 01:54PM U.S. utility MDU Resources backs its strategy after Meister's Corvex takes stake
Aug 8, 2022 04:16PM Form SC 13D MDU RESOURCES GROUP INC Filed by: Corvex Management LP
May 16, 2022 04:02PM Form 13F-HR Corvex Management LP For: Mar 31
May 4, 2022 09:54AM Response to Corvex Management's statement
May 4, 2022 07:41AM Kindred shareholder urges Swedish gaming group to consider sale
May 4, 2022 02:30AM Corvex Statement on Kindred Group Investment
Apr 29, 2022 11:54AM Notification of major holdings in Kindred Group plc
Mar 29, 2022 04:03PM Form SC 13D/A Anaplan, Inc. Filed by: Corvex Management LP
Mar 22, 2022 09:16AM Form SC 13D/A Anaplan, Inc. Filed by: Corvex Management LP
Mar 18, 2022 04:00PM Form 13F-HR/A Corvex Management LP For: Dec 31
Mar 17, 2022 05:01PM Form SC 13D Anaplan, Inc. Filed by: Corvex Management LP
Mar 14, 2022 04:05PM Sema4 Reports Fourth Quarter and Full Year 2021 Financial Results and Business Highlights
Mar 14, 2022 04:05PM Sema4 Reports Fourth Quarter and Full Year 2021 Financial Results and Business Highlights
Feb 17, 2022 06:13AM Notification of major holdings in Kindred Group plc
Feb 14, 2022 04:00PM Form 13F-HR Corvex Management LP For: Dec 31
Feb 14, 2022 09:01AM MGM Resorts (MGM) And IAC (IAC) Announce Agreement To Purchase 9M Shares Of MGM Resorts Common Stock From Corvex Management Lp
Feb 14, 2022 09:00AM MGM RESORTS INTERNATIONAL AND IAC ANNOUNCE AGREEMENT TO PURCHASE 9M SHARES OF MGM RESORTS COMMON STOCK FROM CORVEX MANAGEMENT LP
Dec 17, 2021 12:45PM EQRx Debuts as Publicly Traded Company to Develop and Deliver Innovative Medicines at Radically Lower Prices
Dec 17, 2021 12:45PM EQRx Debuts as Publicly Traded Company to Develop and Deliver Innovative Medicines at Radically Lower Prices
Dec 14, 2021 07:20AM Centene settles with activist Politan, overhauls board, CEO to exit
Dec 2, 2021 07:00AM EQRx and CM Life Sciences III Announce Effectiveness of Form S-4 Registration Statement and Stockholder Meeting Details to Vote on Proposed Business Combination
Nov 29, 2021 08:00AM EQRx to Present at the 4th Annual Evercore ISI HealthCONx Conference
Nov 22, 2021 07:00AM EQRx Announces Partnership Agreement with Abdul Latif Jameel Health to Commercialize Lead Oncology Programs in Middle East, Turkey and Africa
Nov 18, 2021 07:00AM EQRx and Evotec Announce Integrated Drug Discovery and Development Partnership
Nov 16, 2021 08:00AM EQRx Launches “Remaking Medicine: On The Record” Investor Video Series
Nov 15, 2021 04:00PM Form 13F-HR Corvex Management LP For: Sep 30
Oct 19, 2021 01:42PM EQRx and NHSE Sign Memorandum of Understanding to Enter into England’s First Population Health Partnership for Cancer Drugs
Oct 13, 2021 04:01PM Turning Point Therapeutics and EQRx Announce Clinical Collaboration to Evaluate Elzovantinib in Combination with Aumolertinib in Patients with EGFR Mutant Met-Amplified Advanced Non-Small Cell Lung Ca
Oct 6, 2021 06:00AM EQRx and Absci Announce Partnership to Discover and Develop Next-Generation Protein-Based Drugs
Oct 6, 2021 06:00AM EQRx and Absci Announce Partnership to Discover and Develop Next-Generation Protein-Based Drugs
Oct 6, 2021 06:00AM EQRx and Absci Announce Partnership to Discover and Develop Next-Generation Protein-Based Drugs
Sep 27, 2021 08:00AM EQRx Appoints Kathy Giusti to Board of Directors
Sep 17, 2021 07:00AM EQRx Announces Presentation of Phase 3 Data Demonstrating a Progression-Free Survival Benefit with Sugemalimab Consolidation Therapy in Patients with Stage III NSCLC at ESMO Congress 2021
Sep 13, 2021 08:40PM EQRx Announces Presentation of Updated Data from Pivotal Phase 3 Study of Anti-PD-L1 Antibody Sugemalimab in Combination with Chemotherapy as a First-Line Treatment for Stage IV NSCLC
Sep 7, 2021 08:00AM EQRx to Present at the Morgan Stanley 19th Annual Global Healthcare Conference
Sep 1, 2021 12:57PM SomaLogic Closes Business Combination and Will Begin Trading Under the Ticker “SLGC” on the Nasdaq Stock Exchange
View More Recent Stories View Older Stories